Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human PD-1 antibody on cancers

Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human PD-1 antibody on cancers

US Patent 8460886 · Granted Jun 11, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antibody2025
Light emitting apparatus, light source unit, and mobile body2025
Biomarkers for determining the effectiveness of immune checkpoint inhibitors2025
Immunosuppresive agent2025
Catalyst, method for preparing catalyst, and method for producing unsaturated ca2024
Bispecific antibody2024
Site-specific radioisotope-labeled antibody using IgG-binding peptide2024
HMGN partial peptide and cancer therapy using the same2024
Immunity enhancing agent for cancer by Allergin-1 antagonist2023
HMGN partial peptide and cancer therapy using the same2023
Biomarker for diagnosis of irritable bowel syndrome2022
Bispecific antibody2021